Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
Sponsor: Cosmos Rx, Inc
Summary
This study will evaluate whether participants with serious lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and pulmonary hypertension who use the FORTISKAP™ smart medication cap - a bottle-top device that tracks prescription bottle openings and sends dose reminders to participants and their care team - take their medications more consistently and experience better health outcomes compared to similar participants receiving standard care without the device. Participation requires no changes to prescribed medications, testing or clinical visits beyond what is already part of routine care; participants use a modified medication bottle equipped with the FORTISKAP™ cap for nine months.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-07
Completion Date
2027-08
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Locations (1)
Pulmonary Disease Clinic, Sentara Norfolk Hospital
Norfolk, Virginia, United States